Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

Scripps Research uses advanced AI computing to speed HIV vaccine development by rapidly analyzing clinical data.

Scripps Research scientists have discovered how some tumors endure DNA damage, revealing a potential new way to target them. The DNA inside our cells is constantly exposed to damage, and one of the ...

The project was backed by NIH and attempted to decode how the nervous system in the human body was capable of monitoring the ...

SAN DIEGO — Scripps Research in La Jolla is celebrating a century of transforming human health. The nonprofit biomedical institute is ranked No. 1 in the world when it comes to innovation. With 100 ...

New research from the Scripps Institution of Oceanography has revealed numerous discarded World War II-era munitions off the Southern California coast — the latest discovery in the team’s efforts to ...

Ten scientists at Scripps Research were honored recently on Clarivate’s annual Highly Cited Researchers list for 2025. The annual list identifies researchers whose publications rank in the top 1 ...

LA JOLLA, CA—According to the US Centers for Disease Control and Prevention, at least 5.8 million Americans are currently living with Alzheimer’s disease, which is the most common form of dementia.

The Scripps Research Center, a La Jolla-based research institution committed to advancing human health through profound discoveries, is celebrating its 100th anniversary by bringing more than 50 ...

Alzheimer’s disease — the most common form of dementia — affects twice as many women as men. Now, there's a new study to try to figure out whether how much sleep women get could be partly to blame.

Scripps Research, a nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation, will celebrate its 100-year history throughout 2024. This significant ...

FRAMINGHAM, MA / ACCESS Newswire / November 19, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immuno-oncology ...